1. Home
  2. INTT vs TNYA Comparison

INTT vs TNYA Comparison

Compare INTT & TNYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo inTest Corporation

INTT

inTest Corporation

HOLD

Current Price

$14.93

Market Cap

175.3M

Sector

Technology

ML Signal

HOLD

Logo Tenaya Therapeutics Inc.

TNYA

Tenaya Therapeutics Inc.

HOLD

Current Price

$0.70

Market Cap

178.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
INTT
TNYA
Founded
1981
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Medicinal Chemicals and Botanical Products
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
175.3M
178.5M
IPO Year
1997
2021

Fundamental Metrics

Financial Performance
Metric
INTT
TNYA
Price
$14.93
$0.70
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
3
Target Price
$13.50
$5.33
AVG Volume (30 Days)
127.2K
3.0M
Earning Date
05-01-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
54.96
EPS
N/A
N/A
Revenue
$66,801,000.00
N/A
Revenue This Year
$15.82
N/A
Revenue Next Year
$9.10
N/A
P/E Ratio
N/A
N/A
Revenue Growth
66.06
N/A
52 Week Low
$5.51
$0.36
52 Week High
$15.66
$2.35

Technical Indicators

Market Signals
Indicator
INTT
TNYA
Relative Strength Index (RSI) 59.57 46.89
Support Level $7.21 $0.65
Resistance Level $15.34 $0.94
Average True Range (ATR) 0.96 0.06
MACD -0.15 -0.01
Stochastic Oscillator 71.72 37.83

Price Performance

Historical Comparison
INTT
TNYA

About INTT inTest Corporation

inTest Corp is a supplier of test and process technology solutions for use in manufacturing and testing across a wide range of markets, including Semi, Auto/EV, Defense/Aerospace, Industrial, Life Sciences, Safety/Security, and Other. The Company has three operating segments, which are also its reportable segments and reporting units: Electronic Test, which generates the majority of its revenue and includes semiconductor test equipment, flying probe, and in-circuit testers; Environmental Technologies, which includes thermal test, process, and storage products; and Process Technologies, which includes induction heating and video imaging products. The Company generates the maximum revenue from the U.S.

About TNYA Tenaya Therapeutics Inc.

Tenaya Therapeutics Inc is a clinical-stage biotechnology company focused on the discovery and development of therapies targeting the underlying mechanisms of heart disease. It is developing therapies for rare genetic disorders as well as for more prevalent heart conditions through three distinct but interrelated product platforms: Gene Therapy, Cellular Regeneration and Precision Medicine. The company's clinical-stage gene therapy candidates include TN-201 and TN-401. It operates in one operating segment, which is the business of discovering and developing potential treatments that address the underlying drivers of heart disease.

Share on Social Networks: